According to the Oncomine database, EZH2 expression was increased in tumor tissues compared with normal tissues and was positively correlated with clinicopathologic features (tumor grades and TNM stages) and the presence of stem cell surface markers (CD133 and CD44) and inversely correlated with Dicer levels (Figure S2D‐I). This evidence concerns the gene PROM1 and neoplasm.